Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $16,400 - $27,000
-20,000 Reduced 33.33%
40,000 $35,000
Q4 2023

Jan 30, 2024

BUY
$0.66 - $0.91 $19,800 - $27,300
30,000 Added 100.0%
60,000 $52,000
Q3 2023

Oct 23, 2023

SELL
$0.85 - $1.43 $5,950 - $10,010
-7,000 Reduced 18.92%
30,000 $27,000
Q4 2022

Feb 10, 2023

BUY
$1.07 - $1.34 $28,890 - $36,180
27,000 Added 270.0%
37,000 $44,000
Q3 2022

Nov 09, 2022

BUY
$1.09 - $1.67 $10,900 - $16,700
10,000 New
10,000 $11,000
Q1 2020

May 11, 2020

SELL
$4.0 - $21.53 $38,000 - $204,535
-9,500 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$13.94 - $24.12 $132,430 - $229,140
9,500 New
9,500 $204,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.